Bioluminescent imaging (BLI) revealed that MM cells were effectively limited in mice treated with BCMA or CD47-directed UCAR-T cells and BCMA/CD47-directed UCAR-T cells compared to CD123-directed Nb5-UCART cells and PBS control (Fig. 5B-C, Fig.S5A). Here, CD47 is linked to Miyoshi myopathy.